Navigation Links
Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
Date:2/9/2011

ssociated with numerous disorders, including those with inflammatory components, aberrant immune response and/or inappropriate cell proliferation.  The provisional application indicates that the disorders which may be treated with this discovery include inflammation occurring in brain swelling or neurodegenerative disease such as Alzheimer's disease, multiple sclerosis and Parkinson's disease.  

Recent work at the Roskamp Institute in Sarasota, Florida, has shown that S-(-)anatabine differs in potency from the racemate and is supportive of further development of S-(-)anatabine.  Curtis Wright, IV, MD/MPH, Chief Medical Officer of Rock Creek Pharmaceuticals, stated, "We believe that this intriguing development holds within it the seeds of a new drug, and that this preparation of the an active isomer in a commercially viable form is a positive outcome toward that goal."

Star Scientific also is working with McColl Partners LLC on structuring a controlled auction for bidding by pharmaceutical companies for licensing and/or co-venturing relationships.  McColl previously has advised the company on a range of corporate finance matters, including the assessment of strategic initiatives involving new products.  McColl Partners, an independent investment banking firm co-founded by Hugh McColl, former Chairman of Bank of America, specializes in the needs of management and owners of middle-market companies.  The firm offers strategic advice and assistance to its clients regarding mergers and acquisitions.

Certain statements in this press release other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
2. First CyberKnife VSI System Installed at Creekside Cancer Care
3. Access Pharmaceuticals Receives Early MuGard Prescriber Anecdotal Feedback Validating Larger Target Market Potential
4. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
5. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
6. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
7. Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
8. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
9. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
10. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
11. Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg / 500 mg, NDC 0603-3888-20, 60 Count, Lot Numbers T150G10B, T120J10E and T023M10A and Phenobarbital Tablets, USP 32.4 mg, ND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... N.C. , July 2, 2015 ... employees to capture critical product and market insights ... many benefits to employee-based studies, it is essential ... their own internal employees to capture critical business-related ... by benchmarking firm, Best Practices, LLC, most benchmarked ...
(Date:7/2/2015)... CHAPEL HILL, N.C. , July 2, 2015 /PRNewswire/ ... industry. Because of its leading role in educating thought ... the functions that can heavily influence how well a ... to a new study from research and consulting leader ... Medical Affairs leaders need to focus on are early ...
(Date:7/2/2015)... OXFORD, England , July 2, 2015 ... commonly known as ,Friendly Aedes aegypti , ... of Juazeiro, Brazil by 95%, ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The ... of a trial of Oxitec,s genetically engineered mosquitoes. The ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
... BETHESDA, Md., Jan. 20, 2011 Spherix Incorporated ... biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; ... food, supplement, biotechnology and pharmaceutical companies, today announced that ... million of shares of its common stock and warrants ...
... YORK, Jan. 20, 2011 Reportlinker.com announces ... available in its catalogue: ... Opportunity Assessment and Market Forecasts to 2016 ... Glucose Monitoring Systems - Global Pipeline ...
Cached Medicine Technology:Spherix Announces Registered Direct Offering of $2.77 Million 2Spherix Announces Registered Direct Offering of $2.77 Million 3Reportlinker Adds Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3
(Date:7/2/2015)... ... July 02, 2015 , ... ... Delivery Coalition met for the late June Web-based session, the speakers discussed the ... schemes and managing high-risk patients through coordinated care. , During the session, participants ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team at ... herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and spine surgery, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... executing them with care and precision. There is an art and science that ... the honor of successfully reshaping the facial features and lives of more than ...
(Date:7/2/2015)... ... 02, 2015 , ... Breakthrough technologies are now available in ... Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & Physical Therapy Clinic ... of back, hip, knee and shoulder pain as well as sports injury disorders, ...
(Date:7/2/2015)... PA (PRWEB) , ... July 02, 2015 , ... ... Vaccine Research (CVR) recently received nearly $4 million through five federal grants ... develop vaccines and therapies against the deadly diseases. , The research will ...
Breaking Medicine News(10 mins):Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4
... that an immunosuppressive drug used in organ transplant cases ... lupus erythematosus (SLE). SLE results in inflammation of connective ... Its cause is unknown. The findings were announced today ... Rheumatology in Boston. , Our findings show this therapy ...
... over year growth driven by Loestrin 24 and Taclonex; Company ... updates full year 2007 financial guidance, ST. DAVID,S, ... announced its results for the quarter ended,September 30, 2007. Revenue in ... 16.3%, over the prior year quarter. The,primary drivers of the increase ...
... Nurses Organizing Committee Donate $10,000 and Send ... ... Nurses Organizing Committee/California Nurses Association have,donated $10,000 in support of RNs striking ... nurses from around the nation as part,of a solidarity caravan to join ...
... N.J., Nov. 9 Hooper Holmes,Inc. (Amex: HH ... financial results for the third quarter ended September 30,2007. ... to $60.6,million in the corresponding period of 2006. The ... 2007 of $10.6 million, or $(0.16) per share,compared to ...
... due to non-recurring event in 2007, net loss stable ... Canadian dollars unless otherwise noted), BELLEVILLE, ON, Nov. ... research-based, technology-driven Canadian,biopharmaceutical company, today announced financial results for ... 30, 2007. "We are also focused on the ...
... Financial Flexibility To Fund ... ... ) today announced its results for the third quarter and nine,months ended ... sales of approximately $42 million and a net loss of,approximately $29 million, ...
Cached Medicine News:Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:Nurses From Across Nation Join Solidarity Caravan in Support of Striking Kentucky RNs 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 2Health News:Hooper Holmes Announces Third Quarter 2007 Results 3Health News:Hooper Holmes Announces Third Quarter 2007 Results 4Health News:Hooper Holmes Announces Third Quarter 2007 Results 5Health News:Hooper Holmes Announces Third Quarter 2007 Results 6Health News:Hooper Holmes Announces Third Quarter 2007 Results 7Health News:Bioniche Reports Fiscal 2008 First Quarter 2Health News:Bioniche Reports Fiscal 2008 First Quarter 3Health News:Bioniche Reports Fiscal 2008 First Quarter 4Health News:Bioniche Reports Fiscal 2008 First Quarter 5Health News:Bioniche Reports Fiscal 2008 First Quarter 6Health News:Bioniche Reports Fiscal 2008 First Quarter 7Health News:Bioniche Reports Fiscal 2008 First Quarter 8Health News:Bioniche Reports Fiscal 2008 First Quarter 9
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: